Literature DB >> 26183310

Infection of Ixodes spp. tick cells with different Anaplasma phagocytophilum isolates induces the inhibition of apoptotic cell death.

Pilar Alberdi1, Nieves Ayllón2, Alejandro Cabezas-Cruz3, Lesley Bell-Sakyi4, Erich Zweygarth5, Snorre Stuen6, José de la Fuente7.   

Abstract

Anaplasma phagocytophilum is an intracellular rickettsial pathogen transmitted by Ixodes spp. ticks, which causes granulocytic anaplasmosis in humans, horses and dogs and tick-borne fever (TBF) in ruminants. In the United States, human granulocytic anaplasmosis (HGA) is highly prevalent while TBF has not been reported. However, in Europe the situation is the opposite, with high prevalence for TBF in sheep and low prevalence of HGA. The origin of these differences has not been identified and our hypothesis is that different A. phagocytophilum isolates impact differently on tick vector capacity through inhibition of apoptosis to establish infection of the tick vector. In this study we used three different isolates of A. phagocytophilum of human, canine and ovine origin to infect the Ixodes ricinus-derived cell line IRE/CTVM20 and the Ixodes scapularis-derived cell line ISE6 in order to characterize the effect of infection on the level of tick cell apoptosis. Inhibition of apoptosis was observed by flow cytometry as early as 24h post-infection for both tick cell lines and all three isolates of A. phagocytophilum, suggesting that pathogen infection inhibits apoptotic pathways to facilitate infection independently of the origin of the A. phagocytophilum isolate and tick vector species. However, infection with A. phagocytophilum isolates inhibited the intrinsic apoptosis pathway at different levels in I. scapularis and I. ricinus cells. These results suggested an impact of vector-pathogen co-evolution on the adaptation of A. phagocytophilum isolates to grow in tick cells as each isolate grew better in the tick cell line derived from its natural vector species. These results increase our understanding of the mechanisms of A. phagocytophilum infection and multiplication and suggest that multiple mechanisms may affect disease prevalence in different geographical regions.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Anaplasma phagocytophilum; Apoptosis; Ixodes; Porin; Tick cell lines

Mesh:

Substances:

Year:  2015        PMID: 26183310     DOI: 10.1016/j.ttbdis.2015.07.001

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  16 in total

Review 1.  How relevant are in vitro culture models for study of tick-pathogen interactions?

Authors:  Cristiano Salata; Sara Moutailler; Houssam Attoui; Erich Zweygarth; Lygia Decker; Lesley Bell-Sakyi
Journal:  Pathog Glob Health       Date:  2021-06-30       Impact factor: 3.735

2.  Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and Anaplasma phagocytophilum Infection.

Authors:  Marinela Contreras; Pilar Alberdi; Isabel G Fernández De Mera; Christoph Krull; Ard Nijhof; Margarita Villar; José De La Fuente
Journal:  Front Cell Infect Microbiol       Date:  2017-08-09       Impact factor: 5.293

3.  Tick-borne pathogens induce differential expression of genes promoting cell survival and host resistance in Ixodes ricinus cells.

Authors:  Karen L Mansfield; Charlotte Cook; Richard J Ellis; Lesley Bell-Sakyi; Nicholas Johnson; Pilar Alberdi; José de la Fuente; Anthony R Fooks
Journal:  Parasit Vectors       Date:  2017-02-15       Impact factor: 3.876

Review 4.  The Tick Cell Biobank: A global resource for in vitro research on ticks, other arthropods and the pathogens they transmit.

Authors:  Lesley Bell-Sakyi; Alistair Darby; Matthew Baylis; Benjamin L Makepeace
Journal:  Ticks Tick Borne Dis       Date:  2018-05-31       Impact factor: 3.744

5.  Identification of Haemaphysalis longicornis Genes Differentially Expressed in Response to Babesia microti Infection.

Authors:  Weiqing Zheng; Rika Umemiya-Shirafuji; Shengen Chen; Kiyoshi Okado; Paul Franck Adjou Moumouni; Hiroshi Suzuki; Shu Yang; Mingming Liu; Xuenan Xuan
Journal:  Pathogens       Date:  2020-05-14

6.  Tissue-Specific Signatures in the Transcriptional Response to Anaplasma phagocytophilum Infection of Ixodes scapularis and Ixodes ricinus Tick Cell Lines.

Authors:  Pilar Alberdi; Karen L Mansfield; Raúl Manzano-Román; Charlotte Cook; Nieves Ayllón; Margarita Villar; Nicholas Johnson; Anthony R Fooks; José de la Fuente
Journal:  Front Cell Infect Microbiol       Date:  2016-02-10       Impact factor: 5.293

Review 7.  Anaplasma phagocytophilum Manipulates Host Cell Apoptosis by Different Mechanisms to Establish Infection.

Authors:  Pilar Alberdi; Pedro J Espinosa; Alejandro Cabezas-Cruz; José de la Fuente
Journal:  Vet Sci       Date:  2016-07-15

8.  Anaplasma phagocytophilum MSP4 and HSP70 Proteins Are Involved in Interactions with Host Cells during Pathogen Infection.

Authors:  Marinela Contreras; Pilar Alberdi; Lourdes Mateos-Hernández; Isabel G Fernández de Mera; Ana L García-Pérez; Marie Vancová; Margarita Villar; Nieves Ayllón; Alejandro Cabezas-Cruz; James J Valdés; Snorre Stuen; Christian Gortazar; José de la Fuente
Journal:  Front Cell Infect Microbiol       Date:  2017-07-05       Impact factor: 5.293

9.  Ixodes scapularis Tick Cells Control Anaplasma phagocytophilum Infection by Increasing the Synthesis of Phosphoenolpyruvate from Tyrosine.

Authors:  Alejandro Cabezas-Cruz; Pedro J Espinosa; Dasiel A Obregón; Pilar Alberdi; José de la Fuente
Journal:  Front Cell Infect Microbiol       Date:  2017-08-17       Impact factor: 5.293

10.  Tick galactosyltransferases are involved in α-Gal synthesis and play a role during Anaplasma phagocytophilum infection and Ixodes scapularis tick vector development.

Authors:  Alejandro Cabezas-Cruz; Pedro J Espinosa; Pilar Alberdi; Ladislav Šimo; James J Valdés; Lourdes Mateos-Hernández; Marinela Contreras; Margarita Villar Rayo; José de la Fuente
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.